Vyant Bio Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Vyant Bio Inc
CIK #0001349929
EDGAR Form CIK 2011 - 2026
10-K [0001349929]
10-Q [0001349929]
3 [0001349929]
4 [0001349929]
8-K [0001349929]
D [0001349929]
SC 13D [0001349929]
SC 13G [0001349929]
Form 13D/13G Filer Form 13D/13G Subject Filed
FOD Capital LLC Vyant Bio Inc [2022-02-14]
Fivet Investment Management Ltd Cancer Genetics Inc [2021-02-25]
Intracoastal Capital LLC Cancer Genetics Inc [2021-02-09]
Bigger Capital Fund L P Cancer Genetics Inc [2021-02-08]
Lind Global Macro Fund LP Cancer Genetics Inc [2021-02-03]
Fivemore Fund Ltd Cancer Genetics Inc [2020-11-09]
Ionic Ventures LLC Cancer Genetics Inc [2020-11-02]
Alpha Capital Anstalt Cancer Genetics Inc [2020-10-30]
Renaissance Technologies LLC Cancer Genetics Inc [2020-02-12]
Sabby Management LLC Cancer Genetics Inc [2019-01-10]
View All
Form 3/4/5 Subject 2011 - 2026
Cancer Genetics Inc
Hansen Paul R
Fletcher R John
Harris Geoffrey E
Horobin Joanna
Boehm Marcus
McLeod Howard
Yeh Yung-Ping
Fremeau Robert Thomas Jr
Roberts John A
LaFrence Andrew DC
Brandt Ralf
Miles Michael Glenn
Prendergast Franklyn G
Cannon Edmund
Chaganti Raju SK
Pappajohn John
Finger William Lansing
McCartney Michael Brian
Shaknovich Rita
Widmann Thomas F
Welsh Michael J
Gitelman Igor
Sharma Panna
Sitar Edward J
Hepburn Steven
El Naggar Jane Houldsworth
Rothman Paul
Brownlie Keith L
Pecora Andrew L
Thompson Tommy G
Czerepak Elizabeth
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2023-01-17 Grant 4,368
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2023-01-17 Grant 5,712
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2023-01-17 Grant 7,526
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2023-01-17 Grant 4,032
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-11-18 Sell 666 $1.33 886
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-11-18 Sell 99 $1.34 133
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-10-17 Grant 10,841
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-10-17 Grant 14,285
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-10-17 Grant 7,653
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-10-17 Grant 8,290
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-07-18 Grant 4,696
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-07-18 Grant 8,092
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-07-18 Grant 6,141
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-07-18 Grant 4,335
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-04-18 Grant 5,157
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-04-18 Grant 6,796
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-04-18 Grant 3,640
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-04-18 Grant 3,944
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-04-18 Grant 7,281
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
2022-03-30 Grant 43,478
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com